ARCHIVES

Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials

This article is from The Cancer Letter archive.

Vol. 04 No. 36 | September 8, 1978

Download PDF Visit The Full Archive

Related Articles

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010

Toxicology Program Seeks Comment On Substances.

March 23, 2001

Satraplatin Improved PFS In Refractory Prostate Cancer

July 25, 2003

Court Filing By Fisher; Board, Attacks Interim NSABP Leadership

August 12, 1994

Cancer Program Critic Epstein Invited To NCAB T Make Argument: “We’re Losing War In Cancer”

May 1, 1992

Research Base Would Be Increased In Guideline Change

November 9, 1990